leadf
logo-loader
viewWeedMD Inc

WeedMD kicks off 2021 with the development of new Cannabis 2.0 products

WeedMD said its newest Cannabis 2.0 extract products are expected to debut during 2Q 2021, under the company's Color Cannabis and Saturday Cannabis adult-use brands

WeedMD Inc -
Its expanded portfolio is tailor-made for consumers looking for richer cannabis concentrates and alternative cannabis consumption methods

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) announced that it is developing new Cannabis 2.0 products as it enters 2021, with extract products featuring live resin, solventless hash, and rosin concentrates. 

The company said its newest Cannabis 2.0 extract products are expected to debut during the second quarter of 2021, under WeedMD’s Color Cannabis and Saturday Cannabis adult-use brands. 

“WeedMD’s genetic library boasts unique strains, with flavour and aroma profiles widely recognized throughout the industry and we are thrilled to announce we are now expanding into high-value, terpene-rich hash, live resin and rosin products,” WeedMD Interim CEO George Scorsis said in a statement.

READ: WeedMD on a pathway to profitable growth as it accelerates its Cannabis 2.0 efforts

He added: “We are listening to our consumers and retail partners in developing these products and extending our portfolio. Our cultivation, commercial and product teams are now capturing these profiles in a variety of formats, including solventless concentrates and extracts to deliver premium products under our Color and Saturday Cannabis brands.”  

“This expanded portfolio is tailor-made for consumers looking for richer cannabis concentrates and alternative cannabis consumption methods.”

WeedMD noted that product development for both solventless cannabis concentrates (including bubble hash and rosin) and hydrocarbon (live resin) extract products is currently underway alongside the company and its third-party processors.

It added that extract products will be produced using WeedMD’s own biomass, grown on-site at the company’s state-of-the-art greenhouse and outdoor field in Strathroy, Ontario.

WeedMD Inc is the parent company of WeedMD RX Inc and Starseed Medicinal Inc, which are federally licensed producers of cannabis products for both the medical and adult-use markets. The company owns a 158-acre greenhouse, outdoor cultivation and processing facility in Strathroy, Ontario.

Contact Sean at sean@proactiveinvestors.com

Quick facts: WeedMD Inc

Price: 0.42 CAD

TSX-V:WMD
Market: TSX-V
Market Cap: $88.49 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 12/02/2019

2 min read